Nonclinical Efficacy Testing » Non-Clinical CROs and Agencies » Shokukanken Inc.

Shokukanken Inc.

Table of Contents
Table of Contents

Shokukanken, Inc. (hereinafter referred to as “Shokukanken”) is among the few CROs in Japan specializing in veterinary drugs and conducts a large volume of contracted studies. This overview presents the features of its nonclinical studies, an example disease model, and representative case studies. It is intended as a reference when selecting a CRO for nonclinical studies.

Non-Clinical Studies at Shokukanken

High-quality safety, pharmacology, and pharmacokinetic studies

Shokukanken provides high-quality safety studies, drug efficacy/pharmacology studies, and pharmacokinetic studies in accordance with applicable guidelines. In the veterinary field, the organization conducts contracted studies as a contract research organization (CRO).

To apply for registration of veterinary drugs with Japan’s regulatory authorities, both clinical and nonclinical studies are required to address efficacy, safety, and quality control. Shokukanken supports new-drug development for food-producing animals and companion animals in accordance with GCP and GLP regulations.

In-house Non-Clinical testing and clinical collaborations

Shokukanken conducts nonclinical testing in in-house breeding facilities and performs clinical trials in collaboration with livestock farms. The organization also maintains a robust testing and analytical framework. Available analytical instruments include LC/MS, LC/MS/MS, GC/MS/MS, TOF-MS, and dissolution testers.

Shokukanken conducts programs spanning nonclinical studies, clinical studies, and postmarketing use-results surveys for veterinary drugs. In addition, the organization undertakes veterinary pharmaceutical affairs and consulting services related to marketing authorization and re-examination.

Partner Companies associated with Shokukanken

Fuji Micra Co., Ltd.

Fuji Micra has independently developed ultra-small experimental pigs that weigh under 10 kg and measure less than 80 cm in length at six months of age—small enough to be housed in standard dog cages. Other disease models including atherosclerosis and chronic renal failure Micro Minipigs are available.

Hoku-shin Clinical Co.

Hoku-shin Clinical provides comprehensive contracted clinical laboratory services and consultation related to clinical testing and laboratory equipment, primarily in Nagano Prefecture. As a partner to regional medical institutions, the company supplies reliable clinical laboratory data through outsourced testing services.

Non-Clinical Case Studies — Shokukanken

Quality control testing

Testing is performed based on Attachment 2, “Guidelines for Application Materials for Approval of Veterinary Drugs,” within “Handling of Administrative Affairs Related to the Act on Quality, Efficacy and Safety Assurance of Drugs and Medical Devices.” Conducted test examples stipulated in the Standards for Biological Products for Veterinary Use include safety tests, potency tests, toxicity limit confirmation tests, adventitious virus–negative tests, sterility tests, characteristics tests, pH tests, and moisture-content tests.

Reference source: Official website of the Institute of Food Environment and Hygienehttps://www.shokukanken.com/service/quality-control/

Various toxicity tests

Development studies are conducted under appropriate information storage and management in accordance with GLP and ISO. Available services include toxicity tests and skin irritation tests. Supported species include medaka (for fish) and, among rodents, mice, rats, hamsters, guinea pigs, and rabbits.

Reference source: Official website of the Institute of Food Environment and Hygienehttps://www.shokukanken.com/kensa_cat/consignment-test/general/various-toxicity/

Laboratory of food environment and hygiene (Shokukanken) Company Information

The company's strength lies in its proposals to create "one" from "zero" in business domains ranging from "farms" to "dining tables.

Address 561-21 Araguchi-cho, Maebashi, Gunma prefecture, Japan
Tel 027-230-3411
Website https://www.shokukanken.com/

3 Recommended Contract Research Organizations
for Non-Clinical Studies
— by Target goal and Expertise

In non-clinical development, the choice of contract research organization shapes the quality of the data and the time it takes to reach the next decision. Below, three CROs are introduced by the type of study they support: pharmacology (efficacy) studies, safety studies, and pharmacokinetic (PK/PD) studies. Each summary describes the services the company offers so that you can match a provider to your target and development objective.

Pharmacology (Efficacy) StudiesDisease-Relevant Models for
Translational Drug Evaluation
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/)

SMC Laboratories, Inc.

SMC Laboratories is a specialized non-clinical CRO focused on in vivo pharmacology and efficacy studies using disease-relevant animal models, particularly in fibrosis, inflammation, metabolic diseases, and oncology.

Areas of Expertise
Disease-Relevant Model Portfolio

SMC Laboratories offers models covering the liver, lung, kidney, intestine, and oncology. Its portfolio includes the proprietary STAM™ model for MASH, fibrosis, and hepatocellular carcinoma.

Study Design Based on Target Biology

Study plans are developed around the target biology, mechanism of action, disease stage, and development objective. Pharmacological endpoints can be combined with histopathology, biomarkers, and disease-specific readouts.

Support from Target Validation to Proof of Concept

With experience from more than 1,000 studies for clients in 30 countries, SMC Laboratories supports programs from target validation and candidate selection through in vivo proof-of-concept studies.

Safety StudiesComprehensive Safety Assessment for
Preclinical Development
Charles River Laboratories
Reference: Charles River Laboratories official website (https://www.criver.com/)

Charles River Laboratories

Charles River provides non-clinical toxicology and safety assessment services for programs ranging from exploratory safety studies to IND-enabling development.

Areas of Expertise
General Toxicology Across Study Designs

Services include single- and repeat-dose toxicology, dose-range finding, and general toxicology studies across multiple species and administration routes.

Non-GLP and GLP Study Support

Charles River supports both non-GLP and GLP studies, allowing sponsors to progress from early safety characterization to studies intended for regulatory submissions.

Integrated IND-Enabling Safety Assessment

Toxicology studies can be integrated with toxicokinetics, clinical pathology, histopathology, and safety pharmacology to support interpretation and IND-enabling safety packages.

Pharmacokinetic (PK/PD) StudiesConnecting Drug Exposure with
Pharmacological Response
Inotiv
Reference: Inotiv official website (https://www.inotiv.com/)

Inotiv

Inotiv provides integrated PK/PD, DMPK, and bioanalytical services to characterize drug exposure and its relationship with pharmacological response.

Areas of Expertise
Pharmacokinetic Characterization

PK studies characterize exposure, half-life, clearance, and other pharmacokinetic parameters needed to understand how a candidate behaves in the selected model.

Exposure–Response Evaluation

Pharmacokinetic data can be combined with pharmacodynamic endpoints and bioanalysis to evaluate the relationship between drug exposure and pharmacological response.

Integrated DMPK and Development Support

Integrated DMPK, pharmacology, and safety information supports candidate comparison, dose selection, dosing-frequency optimization, and decisions about subsequent preclinical development.

By Therapeutic Area
Disease Animal Models
and Reviews
Proven Capability, Expertise and Track Record
Top 3 Non-Clinical CRO Services